STANDARD BIOTOOLS INC. 8-K/A

What Happened
Standard BioTools Inc. (ticker: LAB) filed a Form 8-K on February 5, 2026 (Accession No. 0001104659-26-010965) to report matters under Item 9.01 — Financial Statements and Exhibits. The filing states that an Item 9.01(b) exhibit was excluded from the company's original 8-K in reliance on the instructions to that Item.

Key Details

• Filing date: February 5, 2026; SEC Accession No.: 0001104659-26-010965.
• Item involved: 9.01 (Financial Statements and Exhibits); specifically the subsection 9.01(b) exhibit.
• The exhibit was omitted from the original report in reliance on the Item 9.01 instructions (i.e., the company indicated exclusion rather than inclusion at that time).
• The current 8-K addresses that exclusion (and relates to the exhibits portion of the prior filing).

Why It Matters
This is a disclosure housekeeping filing about exhibits to a prior 8-K. For investors, the practical takeaway is to review the current 8-K and any newly filed or updated exhibits on SEC EDGAR to see if material information (financial statements, consents, or other exhibits) has been added or corrected. If you follow LAB, check the amended filing and related documents to confirm whether the newly included exhibit affects the company’s previously reported information.